NAMPT as a Dedifferentiation-Inducer Gene: NAD+ as Core Axis for Glioma Cancer Stem-Like Cells Maintenance.

作者: Antonio Lucena-Cacace , Masayuki Umeda , Lola E. Navas , Amancio Carnero

DOI: 10.3389/FONC.2019.00292

关键词:

摘要: Glioma Cancer Stem-Like Cells (GSCs) are a small subset of CD133+ cells with self-renewal properties and capable initiating new tumors contributing to progression, maintenance, hierarchy, complexity. GSCs highly resistant chemo radiotherapy. These believed be responsible for tumor relapses patients' fatal outcome after developing recurrent Glioblastoma (GBM) or High Grade (HGG). under replicative stress high demands on NAD+ supply repair DNA, maintain capacity induce plasticity. feeds Poly-ADP polymerases (PARP) NAD+-dependent deacetylases (SIRTUINS) GSC phenotype. This energetic core axis is mainly controlled by the rate-limiting enzyme nicotinamide phosphoribosyltransferase (NAMPT), an important oncogene dedifferentiation. Targeting depicts frontier in therapy; hence NAMPT could represent key regulator maintenance. Its inhibition may attenuate decreasing supply, consequently better together current therapies control.

参考文章(109)
G A Brooks, Lactate production under fully aerobic conditions: the lactate shuttle during rest and exercise Federation proceedings. ,vol. 45, pp. 2924- 2929 ,(1986)
Nadia Sawicka-Gutaj, Joanna Waligórska-Stachura, Mirosław Andrusiewicz, Maciej Biczysko, Jerzy Sowiński, Jerzy Skrobisz, Marek Ruchała, Nicotinamide phosphorybosiltransferase overexpression in thyroid malignancies and its correlation with tumor stage and with survivin/survivin DEx3 expression Tumor Biology. ,vol. 36, pp. 7859- 7863 ,(2015) , 10.1007/S13277-015-3506-Z
Pernille Kaae Holm, Dann Hansen, Christina Mørk Hansen, Lise Binderup, Rolf Larsson, Cyanoguanidine CHS 828 induces programmed cell death with apoptotic features in human breast cancer cells in vitro. Anticancer Research. ,vol. 20, pp. 4211- 4220 ,(2000)
Mikio Takeuchi, Tomoko Yamamoto, Apoptosis induced by NAD depletion is inhibited by KN-93 in a CaMKII-independent manner. Experimental Cell Research. ,vol. 335, pp. 62- 67 ,(2015) , 10.1016/J.YEXCR.2015.05.019
Kenneth Aldape, Gelareh Zadeh, Sheila Mansouri, Guido Reifenberger, Andreas von Deimling, Glioblastoma: pathology, molecular mechanisms and markers Acta Neuropathologica. ,vol. 129, pp. 829- 848 ,(2015) , 10.1007/S00401-015-1432-1
Giulio Magni, Adolfo Amici, Monica Emanuelli, Nadia Raffaelli, Silverio Ruggieri, Enzymology of Nad+Synthesis Advances in Enzymology - and Related Areas of Molecular Biology. ,vol. 73, pp. 135- 182 ,(1999) , 10.1002/9780470123195.CH5
Benno Rattel, Katja Wosikowski, Max Hasmann, Isabel Schemainda, Roland Löser, Karin Mattern, WK175, a Novel Antitumor Agent, Decreases the Intracellular Nicotinamide Adenine Dinucleotide Concentration and Induces the Apoptotic Cascade in Human Leukemia Cells Cancer Research. ,vol. 62, pp. 1057- 1062 ,(2002)
Andrew Morokoff, Wayne Ng, Andrew Gogos, Andrew H. Kaye, Molecular subtypes, stem cells and heterogeneity: Implications for personalised therapy in glioma. Journal of Clinical Neuroscience. ,vol. 22, pp. 1219- 1226 ,(2015) , 10.1016/J.JOCN.2015.02.008
Jinkuk Kim, In-Hee Lee, Hee Jin Cho, Chul-Kee Park, Yang-Soon Jung, Yanghee Kim, So Hee Nam, Byung Sup Kim, Mark D. Johnson, Doo-Sik Kong, Ho Jun Seol, Jung-Il Lee, Kyeung Min Joo, Yeup Yoon, Woong-Yang Park, Jeongwu Lee, Peter J. Park, Do-Hyun Nam, Spatiotemporal Evolution of the Primary Glioblastoma Genome Cancer Cell. ,vol. 28, pp. 318- 328 ,(2015) , 10.1016/J.CCELL.2015.07.013